DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported that Moody’s Investors Service has assigned ICON a corporate credit rating of Baa3 and Standard & Poor’s, has assigned ICON a corporate credit rating of BBB-, both with a stable outlook.
